Medical News

RSS

In vivo structure of senile plaques in brains of people with Alzheimer's disease

A team of scientists from Britain and the United States believe they may have identified the true in vivo structure of the senile plaques that are characteristically found in the brains of people with Alzheimer's disease.

11 Jun 2010

Clinical data from investigational study of patients with multiple myeloma presented at ASCO

Celgene International Sàrl announced clinical data from an investigational study of patients with multiple myeloma who were younger than 65 years old and received either lenalidomide (REVLIMID), melphalan and prednisone or melphalan plus autologous stem cell transplant (MEL200) following an induction treatment of lenalidomide plus low-dose dexamethasone (Rd) were presented at the American Society of Clinical Oncology annual meeting.

11 Jun 2010

CinGx safe and effective for treating diabetes, Alzheimer’s and dementia

There is currently no cure for Diabetes, Alzheimer's and Dementia but they can be treated and prevented. Allegiance Equity developed CinGx™ as a safe and effective treatment for these diseases.

11 Jun 2010

Anoxia-induced suspended animation helps survive hypothermia

How is it that some people who apparently freeze to death, with no heart rate or respiration for extended periods, can be brought back to life with no long-term negative health consequences? New findings from the laboratory of cell biologist Mark B. Roth, Ph.D., of Fred Hutchinson Cancer Research Center, may help explain the mechanics behind this widely documented phenomenon.

11 Jun 2010

HL survivors do not receive recommended cancer screening tests: Study

A population-based study of 2,071 Hodgkin lymphoma survivors over 15 years has discovered that while many survivors had multiple X-rays and CT scans years after treatment was finished, they often did not receive recommended cancer screening tests.

11 Jun 2010

FRC supports new blood donation policy

Tomorrow (Friday, June 11), Family Research Council Senior Fellow Peter Sprigg will testify before the Advisory Committee on Blood Safety and Availability (ACBSA) of the Department of Health and Human Services.

11 Jun 2010

2010 GAPS sheds light on the painful reality of what life is like for gout patients

The 2010 Gout Attitudes Patient Survey, a new study of Americans with gout, released by Men's Health Network, sheds light on the painful reality of what life is like for the approximately five million Americans who live with this condition. Of those surveyed, 69 percent described the pain of a gout attack as "miserable," yet a quarter of gout patients feel that those without gout perceive them as overreacting to attacks, and 67 percent feel as though others do not take the condition seriously.

11 Jun 2010

Abraxis BioScience presents phase 3 trial data on metastatic malignant melanoma

Abraxis BioScience, Inc. presented trial design information from its ongoing phase 3 registration trial of nanoparticle albumin bound (nab®) driven chemotherapy, nab-paclitaxel (ABRAXANE® for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension), in melanoma, an aggressive form of skin cancer that affects more than 68,000 people in the U.S. each year.

11 Jun 2010

UNITAID approves plan: Solidarity levy to provide funding for health Millennium Development Goals

At a meeting which ended last night, the Executive Board of UNITAID approved a plan to step up efforts to enlist more countries to apply a solidarity levy on air tickets to provide additional funding for the health Millennium Development Goals. The Board approved a number of resolutions, among them the final phase of the establishment of a medicines patent pool, but a situation of depleting funds raises concerns for the many patients currently being treated by UNITAID.

11 Jun 2010

Cubist to oppose Teva’s attempt to add new defense in patent infringement litigation

Cubist Pharmaceuticals, Inc. today announced that it will oppose a motion filed by the Teva defendants to amend their answer to add a new defense in the patent litigation between Cubist and Teva pending in the US District Court for the District of Delaware. A motion for leave to amend the answer is a request to be permitted to add a new allegation. The Teva defendants seek leave to amend their answer to allege that US Patent Nos. 6,468,967 and 6,852,689 are unenforceable due to inequitable conduct.

11 Jun 2010

Perceptive Informatics releases new web-based version of DataLabs Designer module

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today released a new web-based version of the DataLabs Designer™ module, which is part of Perceptive's DataLabs® Electronic Data Capture (EDC) solution. The web-based study design tool, which can be hosted by Perceptive, provides clinical study teams worldwide with online access to collaboratively design trials. This core capability assists in streamlining workflow and improving the efficiency of the study design process.

11 Jun 2010

High work pressure and low job satisfaction may trigger early retirement

Poor health is the most important reason why workers decide to take early retirement, but factors such as high work pressure and low job satisfaction also play a role, reports a study in the June Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

11 Jun 2010

UK scientists discover cancer-blocking activity in Down's syndrome chromosome

Cancer Research UK scientists have discovered cancer-blocking activity for genes carried on chromosome 21 - an extra copy of which is carried by people with Down's syndrome, reveals research published in Nature.

11 Jun 2010

ViroStatics, Vichem Chemie partner to discover new AV-HALT drugs

ViroStatics, srl, an Italian-US biopharmaceutical company today announced the formation of a strategic partnership with Vichem Chemie of Budapest, Hungary to identify, synthesize, screen, and develop the next generation of AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) for the treatment of HIV/AIDS and other chronic diseases.

11 Jun 2010

HITN launches Mi Salud Primero initiative that responds to health disparities of Latinos living in the U.S.

HITN announces the launch of "Mi Salud Primero" at the 53rd National Puerto Rican Day Parade on Sunday, June 13th, 2010. "Mi Salud Primero" is a comprehensive, multi-year initiative that supports First Lady Michelle Obama's "Let's Move" campaign. "Mi Salud Primero" and its 5 Step Challenge, responds to the health disparities of Latinos living in the U.S. and will become a key resource for the community it serves, promoting physical health via nutrition, exercise and preventative care, as well as provide much needed information on healthcare.

11 Jun 2010

Repros receives FDA confirmation on lifting of full clinical hold on Proellex

Repros Therapeutics Inc. today announced it has received written confirmation from the FDA noting the full clinical hold on Proellex® has been lifted. The Company will be allowed to run a single study under the new partial clinical hold status. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion.

11 Jun 2010

New undergraduate major in health sector management and policy launched

The University of Miami School of Business Administration today announced that it will offer a new undergraduate major in health sector management and policy beginning in fall 2010. The major is designed to prepare students for business careers within the health care industry, as well as to pursue advanced degree programs in health administration, health economics, medical sociology and public health.

11 Jun 2010

Medical News

In vivo structure of senile plaques in brains of people with Alzheimer's disease

Clinical data from investigational study of patients with multiple myeloma presented at ASCO

CinGx safe and effective for treating diabetes, Alzheimer’s and dementia

Anoxia-induced suspended animation helps survive hypothermia

HL survivors do not receive recommended cancer screening tests: Study

FRC supports new blood donation policy

2010 GAPS sheds light on the painful reality of what life is like for gout patients

Abraxis BioScience presents phase 3 trial data on metastatic malignant melanoma

UNITAID approves plan: Solidarity levy to provide funding for health Millennium Development Goals

Cubist to oppose Teva’s attempt to add new defense in patent infringement litigation

Perceptive Informatics releases new web-based version of DataLabs Designer module

High work pressure and low job satisfaction may trigger early retirement

UK scientists discover cancer-blocking activity in Down's syndrome chromosome

ViroStatics, Vichem Chemie partner to discover new AV-HALT drugs

HITN launches Mi Salud Primero initiative that responds to health disparities of Latinos living in the U.S.

Repros receives FDA confirmation on lifting of full clinical hold on Proellex

New undergraduate major in health sector management and policy launched

China-Biotics fourth-quarter revenues up 64.4% to $25.5 million

Sodexo and Procter & Gamble win EuroFM Award

Investment report on Novavax

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News